Copertina

GPCR and CDK proteins' target-drug interactions, HIV and COV proteins' target-target interactions, and GPCR and CDK proteins' mutated sequences

Fuente: Zenodo

Salvato in:

Dettagli Bibliografici
Autore principale:	Harrouche, Oussama
Natura:	Recurso digital
Pubblicazione:	Zenodo 2025
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

GPCR‐G protein selectivity revealed by structural pharmacology
di: Sarah M. Bernhard, et al.
Pubblicazione: (2024)

GPCR dimerization: Drug discovery aspects and targets in renin‐angiotensin systems
di: Tahmid Faisal, et al.
Pubblicazione: (2025)

Kinase targeting in Luminal B breast cancer: CDK5.
di: Mamoor, Shahan
Pubblicazione: (2025)

Unlocking mitochondrial drug targets: The importance of mitochondrial transport proteins
di: Charlotte A. Hoogstraten, et al.
Pubblicazione: (2024)

Therapeutic targeting in breast cancer for the treatment of lung metastasis: CDK7.
di: Mamoor, Shahan
Pubblicazione: (2025)

IgE-FcεRI protein-protein interaction as a therapeutic target against allergic asthma: An updated review.
di: Liu, Yan-Jun, et al.
Pubblicazione: (2025)

Input files, parameters, and scripts used for the computational mapping and targeting of BK channel protein–protein interactions in breast cancer
di: Vergara-Jaque, Ariela, et al.
Pubblicazione: (2026)

Relevance of G protein‐coupled receptor (GPCR) dynamics for receptor activation, signalling bias and allosteric modulation
di: Marta Lopez‐Balastegui, et al.
Pubblicazione: (2024)

Engineering IGF2 for Lysosome‐targeting chimeras development to target drug‐resistant membrane proteins in tumor therapy
di: Yanchao Pan, et al.
Pubblicazione: (2025)

Discovering new mode‐of‐action pesticide leads inhibiting protein–protein interactions: example targeting plant O ‐acetylserine sulfhydrylase
di: Rotem Shelly Ben‐Shushan, et al.
Pubblicazione: (2024)

GPCR-Filter: a deep learning framework for efficient and precise GPCR modulator discovery
di: Ning, Jingjie, et al.
Pubblicazione: (2026)

ApexGen: Simultaneous design of peptide binder sequence and structure for target proteins
di: Xia, Xiaoqiong, et al.
Pubblicazione: (2025)

Unlocking GPCR–ligand interactions: Measuring binding affinities with thermal shift assay
di: Dmitrii Dashevskii, et al.
Pubblicazione: (2025)

Heterogeneous networks in drug-target interaction prediction
di: Molaee, Mohammad, et al.
Pubblicazione: (2025)

CDK6 protein expression is associated with disease progression and treatment resistance in multiple myeloma
di: Johannes Steinhart, et al.
Pubblicazione: (2024)

Development of tau targeted protein degraders for Alzheimer disease
di: Lisha Wang, et al.
Pubblicazione: (2024)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CDK4.
di: Mamoor, Shahan
Pubblicazione: (2026)

Lysosome‐targeting chimera (LYTAC): A silver bullet for targeted degradation of oncogenic membrane proteins
di: Qingquan Zheng, et al.
Pubblicazione: (2024)

Privileged proteins with a second residence: dual targeting and conditional re‐routing of mitochondrial proteins
di: Ophry Pines, et al.
Pubblicazione: (2024)

Mechanisms governing GPCR anterograde transport
di: Kevin Assoumou, et al.
Pubblicazione: (2025)

GPCR microswitch analysis scripts and data
di: Ji, Jingjing, et al.
Pubblicazione: (2026)

Computational modeling and experimental validation of the interaction between tumor biomarker mesothelin and an engineered targeting protein with therapeutic activity
di: Margherita Piccardi, et al.
Pubblicazione: (2025)

Sequence-based protein-protein interaction prediction and its applications in drug discovery
di: Charih, François, et al.
Pubblicazione: (2025)

Glycopolymers stabilize protein folding and protein–protein interactions via enthalpic interactions
di: Sabrina M. Richter, et al.
Pubblicazione: (2025)

Utilizing aptamers in targeted protein degradation strategies for disease therapy
di: Lin Li, et al.
Pubblicazione: (2025)

Theranostics targeting fibroblast activation protein in the pan‐cancer field
di: Yutao Li, et al.
Pubblicazione: (2025)

Redirecting TRIM21 with TRIMTACs for the targeted degradation of multimeric proteins
di: Marc A. Scemama de Gialluly, et al.
Pubblicazione: (2026)

Construction of a versatile fusion protein for targeted therapy and immunotherapy
di: Xiu‐Song Huang, et al.
Pubblicazione: (2024)

The emerging role of targeted protein degradation to treat and study cancer
di: Maximillian H Brodermann, et al.
Pubblicazione: (2024)

The contribution of mRNA targeting to spatial protein localization in bacteria
di: Wenkang Shang, et al.
Pubblicazione: (2024)

Design, synthesis, and analysis of macrobicyclic peptides for targeting the Gαi protein
di: Anna Pepanian, et al.
Pubblicazione: (2024)

De novo design of protein binders targeting the human sweet taste receptor as potential sweet proteins
di: Ding, Saisai, et al.
Pubblicazione: (2026)

Structuring the GPCR Story Through the Lens of NMR
di: Arpita Prasad, et al.
Pubblicazione: (2025)

The GPCR Connection: Linking Alzheimer's Disease and Glioblastoma
di: Ana B. Caniceiro, et al.
Pubblicazione: (2026)

Artificial intelligence streamlines scientific discovery of drug–target interactions
di: Yuxin Yang, et al.
Pubblicazione: (2025)

A large dataset curation and benchmark for drug target interaction
di: Golts, Alex, et al.
Pubblicazione: (2024)

The unfolded protein response is a potential therapeutic target in pathogenic fungi
di: Hao Zhou, et al.
Pubblicazione: (2025)

An archaeal protein nanoparticle platform for cancer cell-specific targeting and therapeutics.
di: Byun, Jun-Hwan, et al.
Pubblicazione: (2025)

Heat shock protein 90: biological functions, diseases, and therapeutic targets
di: Huiyun Wei, et al.
Pubblicazione: (2024)

Mapping protein–protein interactions by mass spectrometry
di: Xiaonan Liu, et al.
Pubblicazione: (2024)